Advertisement
U.S. markets closed

Passage Bio, Inc. (PASG)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
0.5050-0.0310 (-5.78%)
At close: 04:00PM EST
0.5186 +0.01 (+2.69%)
After hours: 04:51PM EST
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0
0
0
0
0
Operating Expense
69,343
102,999
135,394
177,729
111,902
Operating Income
-69,343
-102,999
-135,394
-177,729
-111,902
Net Non Operating Interest Income Expense
-
-
2,269
343
670
Other Income Expense
543
937
-731
-8,000
-1,000
Pretax Income
-68,800
-102,062
-136,125
-185,386
-112,232
Net Income Common Stockholders
-68,800
-102,062
-136,125
-185,386
-112,232
Diluted NI Available to Com Stockholders
-68,800
-102,062
-136,125
-185,386
-112,232
Basic EPS
-2.05
-1.86
-2.50
-3.48
-2.46
Diluted EPS
-2.05
-1.86
-2.50
-3.48
-2.46
Basic Average Shares
54,668
54,743
54,429
53,344
45,615
Diluted Average Shares
54,668
54,743
54,429
53,344
45,615
Total Operating Income as Reported
-74,576
-108,389
-138,394
-185,729
-112,902
Total Expenses
69,343
102,999
135,394
177,729
111,902
Net Income from Continuing & Discontinued Operation
-68,800
-102,062
-136,125
-185,386
-112,232
Normalized Income
-63,567
-96,672
-133,125
-177,386
-111,232
Interest Income
-
-
2,269
343
670
Net Interest Income
-
-
2,269
343
670
EBIT
-69,343
-102,999
-135,394
-177,729
-111,902
EBITDA
-66,174
-99,278
-131,715
-176,186
-111,102
Reconciled Depreciation
3,169
3,721
3,679
1,543
800
Net Income from Continuing Operation Net Minority Interest
-68,800
-102,062
-136,125
-185,386
-112,232
Total Unusual Items Excluding Goodwill
-5,233
-5,390
-3,000
-8,000
-1,000
Total Unusual Items
-5,233
-5,390
-3,000
-8,000
-1,000
Normalized EBITDA
-60,941
-93,888
-128,715
-168,186
-110,102
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0